National Center for Health Research https://www.center4research.org/ The Voice For Prevention, Treatment and Policy Wed, 27 May 2026 22:16:30 +0000 en hourly 1 https://wordpress.org/?v=7.0 https://www.center4research.org/wp-content/uploads/2017/01/nchr-icon-150x150.png National Center for Health Research https://www.center4research.org/ 32 32 NCHR Written Comment to NIH on Post-Trial Needs and Informed Consent for Research Participants Receiving Investigational Implantable Devices https://www.center4research.org/nih-nchr-implantable-device-clinical-trials-patient-protections/ Wed, 27 May 2026 15:29:28 +0000 https://www.center4research.org/?p=23830 May 22, 2026, NCHR submitted comments to NIH on their draft of resources needed for investigational implantable device trials, emphasizing the need for better planning to make sure that patients understand the medical and financial risks of having an experimental implant that may be found to be neither safe nor effective. Patients volunteering for clinical trials of implanted devices deserve to know the risks and be protected from long-term device-related risks and medical care.

The post NCHR Written Comment to NIH on Post-Trial Needs and Informed Consent for Research Participants Receiving Investigational Implantable Devices first appeared on National Center for Health Research.

The post NCHR Written Comment to NIH on Post-Trial Needs and Informed Consent for Research Participants Receiving Investigational Implantable Devices appeared first on National Center for Health Research.

]]> Testimony of Dr. Diana Zuckerman at the FDA Oncology Drugs Advisory Committee on TRUQAP https://www.center4research.org/truqap-zuckerman-oral-statement-fda-oncology-advisory-committee/ Fri, 15 May 2026 21:51:47 +0000 https://www.center4research.org/?p=23818 FDA Oncology Advisory Committee on TRUQAP, April 30, 2026: NCHR president Dr. Diana Zuckerman expressed her concerns about the serious risks and uncertain benefits of TRUQAP given that there is no evidence that it improves overall survival

The post Testimony of Dr. Diana Zuckerman at the FDA Oncology Drugs Advisory Committee on TRUQAP first appeared on National Center for Health Research.

The post Testimony of Dr. Diana Zuckerman at the FDA Oncology Drugs Advisory Committee on TRUQAP appeared first on National Center for Health Research.

]]> Testimony of Dr. Diana Zuckerman at the FDA Oncology Drugs Advisory Committee on Breast Cancer https://www.center4research.org/zuckerman-oral-statement-fda-oncology-advisory-committee-breast-cancer-april30-2026/ Fri, 15 May 2026 21:45:03 +0000 https://www.center4research.org/?p=23814 FDA Oncology Advisory Committee, April 30, 2026: NCHR president Dr. Diana Zuckerman expressed her concerns about uncertain evidence in the SERENA-6 trial of camizestrant in patients with ER+HER2 advanced breast cancer in combination with a CDK4/6 inhibitor plus aromatase inhibitor upon detection of an ESRI biomarker.

The post Testimony of Dr. Diana Zuckerman at the FDA Oncology Drugs Advisory Committee on Breast Cancer first appeared on National Center for Health Research.

The post Testimony of Dr. Diana Zuckerman at the FDA Oncology Drugs Advisory Committee on Breast Cancer appeared first on National Center for Health Research.

]]> NCHR Written Comment to AHRQ on Improving the Management of Menopausal Symptoms in Perimenopausal and Early Postmenopausal Women https://www.center4research.org/ahrq-menopause-hormones-review-nchr-safety-concerns/ Thu, 14 May 2026 20:16:50 +0000 https://www.center4research.org/?p=23805 May 13, 2026, NCHR submitted comments in response to AHRQ’s request for feedback on its research protocol that will inform the NIH Pathways to Prevention Workshop on Improving the Management of Menopausal Symptoms. NCHR urged AHRQ to include all relevant studies rather than exclude foundational evidence through publication date cutoffs. We are especially concerned at the exclusion of long-term Women's Health Initiative (WHI) findings, and to provide unbiased, easy-to-understand information about the risks and benefits of different menopause treatments.

The post NCHR Written Comment to AHRQ on Improving the Management of Menopausal Symptoms in Perimenopausal and Early Postmenopausal Women first appeared on National Center for Health Research.

The post NCHR Written Comment to AHRQ on Improving the Management of Menopausal Symptoms in Perimenopausal and Early Postmenopausal Women appeared first on National Center for Health Research.

]]> Next FDA chief to face similar headwinds after Makary’s ouster https://www.center4research.org/thehill-fda-replace-makary-zuckerman-quote/ Thu, 14 May 2026 17:41:14 +0000 https://www.center4research.org/?p=23801 The Hill, May 14, 2026: The next FDA Commissioner will face the same MAHA-MAGA challenges that Marty Makary did, including political interference, funding cuts, and White House interference. NCHR President Diana Zuckerman notes that although Makary offended just about everybody, he lost his job over a few actions (or lack of actions) that the White House did not like, and urges a more scientific, evidence-based FDA rather than one that bends to political appointees, donors, and friends of the White House.

The post Next FDA chief to face similar headwinds after Makary’s ouster first appeared on National Center for Health Research.

The post Next FDA chief to face similar headwinds after Makary’s ouster appeared first on National Center for Health Research.

]]> Makary departs FDA amid turmoil as Diamantas, agency’s top food official, steps in https://www.center4research.org/stat-makary-resignation-chaos-worst-commissioner/ Tue, 12 May 2026 21:13:36 +0000 https://www.center4research.org/?p=23799 STAT News, May 12, 2026: This article describes reasons for the resignation of FDA commissioner Marty Makary. NCHR president Diana Zuckerman calls him the worst FDA commissioner in 40 years because he undermined the scientific credibility of the agency; it became impossible to believe anything he said or the agency decided.

The post Makary departs FDA amid turmoil as Diamantas, agency’s top food official, steps in first appeared on National Center for Health Research.

The post Makary departs FDA amid turmoil as Diamantas, agency’s top food official, steps in appeared first on National Center for Health Research.

]]> F.D.A. Commissioner Marty Makary Resigns After Weeks of Pressure https://www.center4research.org/nyt-fda-makary-resignation-zuckerman/ Tue, 12 May 2026 20:21:53 +0000 https://www.center4research.org/?p=23797 The New York Times, May 12, 2026: FDA Commissioner Makary resigns under pressure after offending almost everyone involved in FDA issues. NCHR president Diana Zuckerman explains that this resignation is inevitable but will be a disaster for the FDA if he is replaced by someone who is selected to primarily please tobacco, anti-abortion, and other industry lobbyists.

The post F.D.A. Commissioner Marty Makary Resigns After Weeks of Pressure first appeared on National Center for Health Research.

The post F.D.A. Commissioner Marty Makary Resigns After Weeks of Pressure appeared first on National Center for Health Research.

]]> Trump’s pick for science director: a Silicon Valley investor with no science background https://www.center4research.org/salon-nsf-nonscientist-jim-oneill-nominee/ Mon, 11 May 2026 16:47:31 +0000 https://www.center4research.org/?p=23790 Salon, May 7, 2026: This Salon news story on Jim O'Neill's controversial nomination as the first nonscientist director of the National Science Foundation (NSF) quotes NCHR's Dr. Diana Zuckerman and other experts explaining why his lack of scientific credentials and ties to the financial world raise serious concerns about the integrity of the agency and potential conflicts of interest.

The post Trump’s pick for science director: a Silicon Valley investor with no science background first appeared on National Center for Health Research.

The post Trump’s pick for science director: a Silicon Valley investor with no science background appeared first on National Center for Health Research.

]]> NCHR Written Comment to FDA on the Plausible Mechanism Framework for Developing Individualized Therapies for Genetic Conditions https://www.center4research.org/nchr-fda-plausible-mechanism-framework-rare-genetic-diseases-concerns/ Thu, 30 Apr 2026 13:41:43 +0000 https://www.center4research.org/?p=23782 April 27, 2026: NCHR raises concerns about the FDA’s proposed plausible mechanism framework for therapies targeting rare and genetic diseases, warning that reliance on such very limited evidence makes it difficult or impossible to make informed choices based on safety and effectiveness, and means even more very high costing unproven drugs, which patients will pay for directly or through health insurance.

The post NCHR Written Comment to FDA on the Plausible Mechanism Framework for Developing Individualized Therapies for Genetic Conditions first appeared on National Center for Health Research.

The post NCHR Written Comment to FDA on the Plausible Mechanism Framework for Developing Individualized Therapies for Genetic Conditions appeared first on National Center for Health Research.

]]> Confused About Red Meat? Why the Evidence Is Not as Simple as the Guidelines https://www.center4research.org/red-meat-cancer-diabetes-heart-disease/ Thu, 23 Apr 2026 19:38:36 +0000 https://www.center4research.org/?p=23769 The 2025–2030 Dietary Guidelines encourage Americans to eat more red meat, but studies of millions of adults tell the opposite story. Adults who regularly eat processed or ultraprocessed meats such as bacon, sausage, and deli meats -- even in small amounts --are more likely to develop heart disease, type 2 diabetes, and several cancers. Adults who often eat unprocessed meats, such as steak and hamburgers, are also more likely to develop those diseases than those who eat little or no red meat, but less likely than those who eat ultraprocessed red meat. A Mediterranean-style diet rich in vegetables, fruits, whole grains, and healthy fats offers a better path to a longer, healthier life.

The post Confused About Red Meat? Why the Evidence Is Not as Simple as the Guidelines first appeared on National Center for Health Research.

The post Confused About Red Meat? Why the Evidence Is Not as Simple as the Guidelines appeared first on National Center for Health Research.

]]>